The novel coronavirus (COVID-19) will spread in the U.S., and hospitals, communities and individuals should ramp up their preparedness efforts, Nancy Messonnier, M.D., director of the Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases said today. “It’s not a question of if but rather a question of when and how many people in this country will have severe illness.”

Communities must implement non-pharmaceutical interventions, or community mitigation measures, to slow the spread of COVID-19, Messonnier said. She emphasized that a COVID-19 pandemic would cause major disruptions to people’s lives and that hospitals may need to add telehealth options and delay elective surgeries.

CDC plans to release community mitigation guidelines for the outbreak, including personal, community and environmental non-pharmaceutical interventions that will build on its 2017 guidelines for preventing pandemic influenza. 

The National Institutes of Health today announced a clinical trial that will evaluate the safety and effectiveness of the investigational antiviral drug remdesivir to treat COVID-19 in adult patients at the University of Nebraska Medical Center. 

State and local labs Monday asked that the Food and Drug Administration allow them to create their own SARS-CoV-2 tests due to issues with a test kit developed by CDC. Twelve labs across the country have a properly working test, and CDC hopes to send new kits to states soon.

The White House Office of Management and Budget yesterday sent Congress a $2.5 billion supplemental budget request for novel coronavirus preparedness and response, including therapeutics, vaccines, personal protective equipment, state and local support, and surveillance, Health and Human Services Secretary Alex Azar told Senate appropriators today.

For the latest information and resources, visit AHA’s coronavirus webpage.
 

Related News Articles

Headline
Older adults frequently experience cognitive impairment after recovering from COVID-19, according to three studies reported last week at an Alzheimer’s…
Headline
Dr. Trestman and Dr. Hochman reflect on the far-reaching effects of the COVID-19 pandemic on the mental health and well-being of health care professionals,…
Headline
The Food and Drug Administration Friday authorized using the monoclonal antibody therapy REGEN-COV for prevention in certain children and adults who are…
Blog
The American Hospital Association and its Society for Healthcare Strategy and Market Development (SHSMD) July 15 hosted “Addressing COVID-19 Vaccine Hesitancy…
Headline
Read a recap and insights from health care leaders during AHA’s July 15 webinar, “Addressing COVID-19 Vaccine Hesitancy in Your Community,” featuring messaging…
Headline
Three-quarters of the 469 COVID-19 cases associated with summer events and large public gatherings this month in Barnstable County, Mass., were in people fully…